𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Defining the risks of mesenchymal stromal cell therapy

✍ Scribed by Prockop, Darwin J.; Brenner, Malcolm; Fibbe, Willem E.; Horwitz, Edwin; Le Blanc, Katarina; Phinney, Donald G.; Simmons, Paul J.; Sensebe, Luc; Keating, Armand


Book ID
120971631
Publisher
Informa plc
Year
2010
Tongue
English
Weight
160 KB
Volume
12
Category
Article
ISSN
1465-3249

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Mesenchymal Stem Cell Therapy || Mesench
✍ Chase, Lucas G.; Vemuri, Mohan C. πŸ“‚ Article πŸ“… 2012 πŸ› Humana Press 🌐 English βš– 158 KB

Over the past decade, significant efforts have been made to develop stem cell-based therapies for difficult to treat diseases. Multipotent mesenchymal stromal cells, also referred to as mesenchymal stem cells (MSCs), appear to hold great promise in regards to a regenerative cell-based therapy for th

Mesenchymal Stem Cell Therapy || Mesench
✍ Chase, Lucas G.; Vemuri, Mohan C. πŸ“‚ Article πŸ“… 2012 πŸ› Humana Press 🌐 English βš– 367 KB

Over the past decade, significant efforts have been made to develop stem cell-based therapies for difficult to treat diseases. Multipotent mesenchymal stromal cells, also referred to as mesenchymal stem cells (MSCs), appear to hold great promise in regards to a regenerative cell-based therapy for th

Mesenchymal Stem Cell Therapy || Mesench
✍ Chase, Lucas G.; Vemuri, Mohan C. πŸ“‚ Article πŸ“… 2012 πŸ› Humana Press 🌐 English βš– 285 KB

Over the past decade, significant efforts have been made to develop stem cell-based therapies for difficult to treat diseases. Multipotent mesenchymal stromal cells, also referred to as mesenchymal stem cells (MSCs), appear to hold great promise in regards to a regenerative cell-based therapy for th